DirectorCenter for Rare Disease and Hemophilia, Department of Pediatrics, Taichung Veterans General HospitalTaichung, Taichung, Taiwan (Republic of China)
OC 30.5 - Efficacy and safety of fidanacogene elaparvovec in adults with moderately severe or severe hemophilia B: updated results from the phase 3 BENEGENE-2 gene therapy trial
Monday, June 24, 202410:30 – 10:45 ICT
PB0492 - Fourth interim analysis of the HEM-POWR Study: A post hoc analysis of real-world effectiveness and safety of damoctocog alfa pegol in previously treated patients with haemophilia A in Taiwan
Monday, June 24, 202413:45 – 14:45 ICT
